GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) NSE

2,642.30

-30.1(-1.13%)

Updated at September 29 02:43PM

Currency In INR

Valuation

Market Cap473.84B
Enterprise Value459.91B
P/E Ratio47.75
PEG Ratio19.51
Price/Sales Ratio12.13
Price/Book Ratio23.25
Enterprise/Revenue11.76
Enterprise/EBITDA33.36

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.25
Operating Margin0.3

Management Effectiveness

Return On Assets0.23
Return On Equity0.54

Income Statement

Revenue37.49B
Revenue/Share220.72
Gross Profit23.58B
EBITDA11.77B
Net Income9.28B
Diluted EPS54.76

Balance Sheet

Total Cash25.22B
Total Cash/Share198.48
Total Debt99.5M
Total Debt/Equity0.01
Current Ratio1.79
Book Value Per Share115.17

Price History

52-Week Change-2.64
52-Week High3,515.7
52-Week Low1,921
Moving Average 50 Days2,837.98
Moving Average 200 Days2,757.08

Statistics

Average Volume99,165
Shares Outstanding169.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate54
Trailing Annual Dividend Yield2.02
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 11, 2018